世界の眼科治療薬/医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4614
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、眼科治療薬/医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他）、用途別市場規模（ドライアイ、アレルギー、緑内障、感染症、網膜疾患、ブドウ膜炎、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・眼科治療薬/医薬品の市場動向
・企業の競争状況、市場シェア
・眼科治療薬/医薬品の種類別市場規模と予測2016-2027（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障、その他）
・眼科治療薬/医薬品の用途別市場規模と予測2016-2027（ドライアイ、アレルギー、緑内障、感染症、網膜疾患、ブドウ膜炎、その他）
・眼科治療薬/医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・眼科治療薬/医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・眼科治療薬/医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・眼科治療薬/医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・眼科治療薬/医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Alcon、Johnson and Johnson Vision Care, Inc.、Bausch & Lomb Incorporated、Novartis AG、Merck Sharp & Dohme Corp.、Regeneron Pharmaceuticals Inc.、Allergan、Pfizer Inc.、Valeant、Bayer AG、Santen Pharmaceuticals Co. Ltd、Genentech, Inc.）
・結論

Market Analysis and Insights: Global Ophthalmic Therapeutics/Drug Market
The global Ophthalmic Therapeutics/Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ophthalmic Therapeutics/Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ophthalmic Therapeutics/Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ophthalmic Therapeutics/Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ophthalmic Therapeutics/Drug market.

Global Ophthalmic Therapeutics/Drug Scope and Market Size
Ophthalmic Therapeutics/Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutics/Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others

Segment by Application
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-allergy
1.2.3 Anti-VEGF Agents
1.2.4 Anti-inflammatory
1.2.5 Anti-glaucoma
1.2.6 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Therapeutics/Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dry Eye
1.3.3 Allergies
1.3.4 Glaucoma
1.3.5 Infection
1.3.6 Retinal Disorders
1.3.7 Uveitis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ophthalmic Therapeutics/Drug Market Perspective (2016-2027)
2.2 Ophthalmic Therapeutics/Drug Growth Trends by Regions
2.2.1 Ophthalmic Therapeutics/Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ophthalmic Therapeutics/Drug Historic Market Share by Regions (2016-2021)
2.2.3 Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2022-2027)
2.3 Ophthalmic Therapeutics/Drug Industry Dynamic
2.3.1 Ophthalmic Therapeutics/Drug Market Trends
2.3.2 Ophthalmic Therapeutics/Drug Market Drivers
2.3.3 Ophthalmic Therapeutics/Drug Market Challenges
2.3.4 Ophthalmic Therapeutics/Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue
3.1.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue (2016-2021)
3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2016-2021)
3.2 Global Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ophthalmic Therapeutics/Drug Revenue
3.4 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio
3.4.1 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics/Drug Revenue in 2020
3.5 Ophthalmic Therapeutics/Drug Key Players Head office and Area Served
3.6 Key Players Ophthalmic Therapeutics/Drug Product Solution and Service
3.7 Date of Enter into Ophthalmic Therapeutics/Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ophthalmic Therapeutics/Drug Breakdown Data by Type
4.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Type (2016-2021)
4.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2022-2027)

5 Ophthalmic Therapeutics/Drug Breakdown Data by Application
5.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Application (2016-2021)
5.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ophthalmic Therapeutics/Drug Market Size (2016-2027)
6.2 North America Ophthalmic Therapeutics/Drug Market Size by Type
6.2.1 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
6.2.2 North America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
6.2.3 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
6.3 North America Ophthalmic Therapeutics/Drug Market Size by Application
6.3.1 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
6.3.2 North America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
6.3.3 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
6.4 North America Ophthalmic Therapeutics/Drug Market Size by Country
6.4.1 North America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
6.4.2 North America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ophthalmic Therapeutics/Drug Market Size (2016-2027)
7.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type
7.2.1 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
7.2.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
7.2.3 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application
7.3.1 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
7.3.2 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
7.3.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
7.4 Europe Ophthalmic Therapeutics/Drug Market Size by Country
7.4.1 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
7.4.2 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size (2016-2027)
8.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type
8.2.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application
8.3.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region
8.4.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ophthalmic Therapeutics/Drug Market Size (2016-2027)
9.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type
9.2.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
9.2.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
9.2.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
9.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application
9.3.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
9.3.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
9.3.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
9.4 Latin America Ophthalmic Therapeutics/Drug Market Size by Country
9.4.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
9.4.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size (2016-2027)
10.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type
10.2.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application
10.3.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country
10.4.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alcon
11.1.1 Alcon Company Details
11.1.2 Alcon Business Overview
11.1.3 Alcon Ophthalmic Therapeutics/Drug Introduction
11.1.4 Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.1.5 Alcon Recent Development
11.2 Johnson and Johnson Vision Care, Inc.
11.2.1 Johnson and Johnson Vision Care, Inc. Company Details
11.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Introduction
11.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
11.3 Bausch & Lomb Incorporated
11.3.1 Bausch & Lomb Incorporated Company Details
11.3.2 Bausch & Lomb Incorporated Business Overview
11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Introduction
11.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.3.5 Bausch & Lomb Incorporated Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Introduction
11.4.4 Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Merck Sharp & Dohme Corp.
11.5.1 Merck Sharp & Dohme Corp. Company Details
11.5.2 Merck Sharp & Dohme Corp. Business Overview
11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Introduction
11.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.5.5 Merck Sharp & Dohme Corp. Recent Development
11.6 Regeneron Pharmaceuticals Inc.
11.6.1 Regeneron Pharmaceuticals Inc. Company Details
11.6.2 Regeneron Pharmaceuticals Inc. Business Overview
11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Introduction
11.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.6.5 Regeneron Pharmaceuticals Inc. Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview
11.7.3 Allergan Ophthalmic Therapeutics/Drug Introduction
11.7.4 Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.7.5 Allergan Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Introduction
11.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.8.5 Pfizer Inc. Recent Development
11.9 Valeant
11.9.1 Valeant Company Details
11.9.2 Valeant Business Overview
11.9.3 Valeant Ophthalmic Therapeutics/Drug Introduction
11.9.4 Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.9.5 Valeant Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Introduction
11.10.4 Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.10.5 Bayer AG Recent Development
11.11 Santen Pharmaceuticals Co. Ltd
11.11.1 Santen Pharmaceuticals Co. Ltd Company Details
11.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
11.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Introduction
11.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.11.5 Santen Pharmaceuticals Co. Ltd Recent Development
11.12 Genentech, Inc.
11.12.1 Genentech, Inc. Company Details
11.12.2 Genentech, Inc. Business Overview
11.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Introduction
11.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
11.12.5 Genentech, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-allergy
Table 3. Key Players of Anti-VEGF Agents
Table 4. Key Players of Anti-inflammatory
Table 5. Key Players of Anti-glaucoma
Table 6. Key Players of Others
Table 7. Global Ophthalmic Therapeutics/Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ophthalmic Therapeutics/Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ophthalmic Therapeutics/Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Ophthalmic Therapeutics/Drug Market Share by Regions (2016-2021)
Table 11. Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Ophthalmic Therapeutics/Drug Market Share by Regions (2022-2027)
Table 13. Ophthalmic Therapeutics/Drug Market Trends
Table 14. Ophthalmic Therapeutics/Drug Market Drivers
Table 15. Ophthalmic Therapeutics/Drug Market Challenges
Table 16. Ophthalmic Therapeutics/Drug Market Restraints
Table 17. Global Ophthalmic Therapeutics/Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Ophthalmic Therapeutics/Drug Market Share by Players (2016-2021)
Table 19. Global Top Ophthalmic Therapeutics/Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutics/Drug as of 2020)
Table 20. Ranking of Global Top Ophthalmic Therapeutics/Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Ophthalmic Therapeutics/Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ophthalmic Therapeutics/Drug Product Solution and Service
Table 24. Date of Enter into Ophthalmic Therapeutics/Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Ophthalmic Therapeutics/Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. Alcon Company Details
Table 65. Alcon Business Overview
Table 66. Alcon Ophthalmic Therapeutics/Drug Product
Table 67. Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 68. Alcon Recent Development
Table 69. Johnson and Johnson Vision Care, Inc. Company Details
Table 70. Johnson and Johnson Vision Care, Inc. Business Overview
Table 71. Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product
Table 72. Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 73. Johnson and Johnson Vision Care, Inc. Recent Development
Table 74. Bausch & Lomb Incorporated Company Details
Table 75. Bausch & Lomb Incorporated Business Overview
Table 76. Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product
Table 77. Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 78. Bausch & Lomb Incorporated Recent Development
Table 79. Novartis AG Company Details
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Ophthalmic Therapeutics/Drug Product
Table 82. Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 83. Novartis AG Recent Development
Table 84. Merck Sharp & Dohme Corp. Company Details
Table 85. Merck Sharp & Dohme Corp. Business Overview
Table 86. Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product
Table 87. Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 88. Merck Sharp & Dohme Corp. Recent Development
Table 89. Regeneron Pharmaceuticals Inc. Company Details
Table 90. Regeneron Pharmaceuticals Inc. Business Overview
Table 91. Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product
Table 92. Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 93. Regeneron Pharmaceuticals Inc. Recent Development
Table 94. Allergan Company Details
Table 95. Allergan Business Overview
Table 96. Allergan Ophthalmic Therapeutics/Drug Product
Table 97. Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 98. Allergan Recent Development
Table 99. Pfizer Inc. Company Details
Table 100. Pfizer Inc. Business Overview
Table 101. Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 102. Pfizer Inc. Recent Development
Table 103. Valeant Company Details
Table 104. Valeant Business Overview
Table 105. Valeant Ophthalmic Therapeutics/Drug Product
Table 106. Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 107. Valeant Recent Development
Table 108. Bayer AG Company Details
Table 109. Bayer AG Business Overview
Table 110. Bayer AG Ophthalmic Therapeutics/Drug Product
Table 111. Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 112. Bayer AG Recent Development
Table 113. Santen Pharmaceuticals Co. Ltd Company Details
Table 114. Santen Pharmaceuticals Co. Ltd Business Overview
Table 115. Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product
Table 116. Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 117. Santen Pharmaceuticals Co. Ltd Recent Development
Table 118. Genentech, Inc. Company Details
Table 119. Genentech, Inc. Business Overview
Table 120. Genentech, Inc. Ophthalmic Therapeutics/Drug Product
Table 121. Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) & (US$ Million)
Table 122. Genentech, Inc. Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmic Therapeutics/Drug Market Share by Type: 2020 VS 2027
Figure 2. Anti-allergy Features
Figure 3. Anti-VEGF Agents Features
Figure 4. Anti-inflammatory Features
Figure 5. Anti-glaucoma Features
Figure 6. Others Features
Figure 7. Global Ophthalmic Therapeutics/Drug Market Share by Application: 2020 VS 2027
Figure 8. Dry Eye Case Studies
Figure 9. Allergies Case Studies
Figure 10. Glaucoma Case Studies
Figure 11. Infection Case Studies
Figure 12. Retinal Disorders Case Studies
Figure 13. Uveitis Case Studies
Figure 14. Others Case Studies
Figure 15. Ophthalmic Therapeutics/Drug Report Years Considered
Figure 16. Global Ophthalmic Therapeutics/Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Ophthalmic Therapeutics/Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Ophthalmic Therapeutics/Drug Market Share by Regions: 2020 VS 2027
Figure 19. Global Ophthalmic Therapeutics/Drug Market Share by Regions (2022-2027)
Figure 20. Global Ophthalmic Therapeutics/Drug Market Share by Players in 2020
Figure 21. Global Top Ophthalmic Therapeutics/Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Therapeutics/Drug as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Ophthalmic Therapeutics/Drug Revenue in 2020
Figure 23. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2016-2021)
Figure 24. Global Ophthalmic Therapeutics/Drug Revenue Market Share by Type (2022-2027)
Figure 25. North America Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027)
Figure 27. North America Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027)
Figure 28. North America Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027)
Figure 29. United States Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027)
Figure 33. Europe Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027)
Figure 34. Europe Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027)
Figure 35. Germany Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Ophthalmic Therapeutics/Drug Market Share by Region (2016-2027)
Figure 45. China Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027)
Figure 53. Latin America Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027)
Figure 54. Latin America Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027)
Figure 55. Mexico Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Ophthalmic Therapeutics/Drug Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Ophthalmic Therapeutics/Drug Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Ophthalmic Therapeutics/Drug Market Share by Country (2016-2027)
Figure 61. Turkey Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Ophthalmic Therapeutics/Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Alcon Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 65. Johnson and Johnson Vision Care, Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 66. Bausch & Lomb Incorporated Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 68. Merck Sharp & Dohme Corp. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 69. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 70. Allergan Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 71. Pfizer Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 72. Valeant Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 73. Bayer AG Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 74. Santen Pharmaceuticals Co. Ltd Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 75. Genentech, Inc. Revenue Growth Rate in Ophthalmic Therapeutics/Drug Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

以下、関連資料のご紹介

世界の眼科用包装市場規模・現状・予測（2021年-2027年）

Global Ophthalmic Packaging Market Size, Status and Forecast 2021-2027
QFJ1-4613 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、眼科用包装の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ガラス製眼科用包装、プラスチック製眼科用包装、その他）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（...

世界のバッテン病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Batten Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-3890 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療薬、造血幹細胞治療薬）、用途別市場規模（病院＆診療所、専門施設）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の大麻薬市場規模・現状・予測（2021年-2027年）

Global Cannabis Drug Market Size, Status and Forecast 2021-2027
QFJ1-3964 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、大麻薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口スプレー型、カプセル型、錠剤型）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の耳鳴り治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Tinnitus Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4960 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、耳鳴り治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血管拡張薬、抗凝固薬、神経栄養薬）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の眼科用オロパタジン市場規模・現状・予測（2021年-2027年）

Global Olopatadine Ophthalmic Market Size, Status and Forecast 2021-2027
QFJ1-5908 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、眼科用オロパタジンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（点眼液0.1％、点眼液0.2％、点眼液0.7％）、用途別市場規模（成人患者、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の眼科用消耗品市場規模・現状・予測（2021年-2027年）

Global Ophthalmic Consumables Market Size, Status and Forecast 2021-2027
QFJ1-5274 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、眼科用消耗品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼内使用、眼球表面素材、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の腸内細菌科感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Enterobacteriaceae Infection Drug Market Size, Status and Forecast 2021-2027
QFJ1-4190 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、腸内細菌科感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベータラクタム薬剤、カルバペネム薬剤、フルオロキノロン薬剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地...

世界のヘモグロビン症用治療薬市場規模・現状・予測（2021年-2027年）

Global Hemoglobinopathy Treatment Drug Market Size, Status and Forecast 2021-2027
QFJ1-4298 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、ヘモグロビン症用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗生物質、ACE阻害剤、ヒドロキシウレア、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規...

世界の好中球減少症生物学的製剤治療市場規模・現状・予測（2021年-2027年）

Global Neutropenia Biologic Drug Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4576 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、好中球減少症生物学的製剤治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フィルグラスチム、ペグフィルグラスチム、レノグラスチム、リペグフィルグラスチム、サルグラモスチム）、用途別市場規模（小売薬局...

世界の海洋性医薬品市場規模・現状・予測（2021年-2027年）

Global Marine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5842 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、海洋性医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、健康補助食品）、用途別市場規模（病院・クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の長寿＆老化防止治療市場規模・現状・予測（2021年-2027年） Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be relucta…
緑内障点眼薬のグローバル市場調査 2019年 The global Anti Glaucoma Eyedrops market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anti Glaucoma Eyedrops volume and value at global level, regional level and company level. From a global perspective…
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Anti-cancer Drug Market The global Small Molecule Targeted Anti-cancer Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の小分子抗腫瘍標的薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Anti-tumor Targted Drug Market The global Small Molecule Anti-tumor Targted Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…